Skip to main content

Shan Zha

NIH Rank #3810
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10365737Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics

NIH Funding · FY2024

Linked Award Amount
$2.4M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#3,810
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Shan Zha. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Shan Zha as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA293675-01R01
    The role of HPF1 in radiation and genotoxic cancer therapy
    $612.7K
    award amount
  • 5R01CA271595-03R01
    The non-catalytic function of PARP2 in DNA repair and cancer therapy
    $565.1K
    award amount
  • 5R01CA275184-03R01
    The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression
    $471.4K
    award amount
  • 2R01CA158073-11A1R01
    The role of ATM in the suppression of lymphoid malignancy
    $429.8K
    award amount
  • 5P30CA013696-49P30
    Cancer Center Support Grant
    $148.2K
    award amount
  • 5P01CA174653-10P01
    DNA double-strand break repair, chromosome translocations and cancer
    $146.4K
    award amount
  • 3R01CA275184-03S1R01
    The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression
    $62.3K
    award amount

Award organization

Organizations that administered FY2024 awards listing Shan Zha as a PI.

FY2024 award administered by Columbia University (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Columbia University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3810
  6. 2024
    Entered Top 25% Nationally
    Ranked #3810
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding
  10. 2026
    Entered Top 10% Nationally
    Ranked #1563